Current Offerings
“Life begins at the end of your comfort zone.”
– Neale Donald Walsch
Rise
Preferred Equity Fund
BENEFITS OF PREFERRED EQUITY FUND
- 18% IRR
- Diversification across 1,233 units
- Quick return of capital – 2 year term
- Preferred position in the capital stack (Priority position behind senior lender)
- Low execution risk and increased probability of predictable outcome
18% IRR
11% Average Cash Flow; 8% Year 1 Actual CoC; 14% Year 2 Actual CoC
1.38x Equity Multiple on a 2-Year Investment Period
$50K Minimum Investment
Timberview Capital is excited to present an exclusive investment opportunity: the Rise Preferred Equity Fund, a portfolio of six stabilized multifamily properties in the Phoenix MSA. This fund is strategically designed to capitalize on the current market conditions, allowing you to secure a senior position in the capital stack while benefiting from strong cash flow and a short investment horizon.
Key Highlights:
- Executive Class Access – Our network gains access to superior returns at a significantly reduced minimum investment of $50,000, typically reserved for $250K+ investors.
- Proven Track Record – Sponsored by Rise48 Equity, a leader in multifamily acquisitions and operations
- Stabilized Assets with Low Execution Risk – All six properties are performing at above-market occupancy, with strong NOI growth, and are cash-flowing immediately.
Learn more about Rise Preferred Equity Fund
Medical Office
Multiple Locations
16-20% targeted base case IRR
25-35% upside scenario IRR
2 to 3x targeted equity multiple
8% preferred return,
90/10 split up to 15% IRR,
70/30 split at 15% IRR
Timberview Capital brings you a unique investment opportunity in medical real estate. With a focus on healthcare and dental offices, this asset class offers long-term leases and recession-resistant tenants, providing a stable foundation for consistent returns. Medical real estate is positioned to grow alongside the increasing demand for healthcare services, making it a smart addition to any diversified portfolio.
Our current Q4-2024 investment opportunity: a portfolio of four medical buildings comprising 7 medical tenants featuring long-term leases. This carefully curated package offers the potential for robust financial performance
Learn more about Medical Office
10Y Rise
Multiple Locations
Value-Add and Ground Up New Construction
2x Target Equity Multiple, 5 deal cycles
2x Multiple * 5 cycles = 32x Projected Return
$300k investment projected to yield 9.6 million in 10-12 years
10Y is an Exponential Wealth Multiplier Fund. The fund will invest primarily in Multifamily Assets – both Value-Add and Ground Up Construction.
The fund will invest in a collection of properties rather than a single property. This strategy yields two distinctive advantages:
- Diversification of Limited Partner Investments across multiple properties, thereby mitigating the risks associated with a single property investment.
- Ability of the fund to combine depreciation benefits of the properties being held to offset capital gains from the property being sold, resulting in tax-free sale proceeds in each Deal Cycle.
10Y is seeking to raise a total investment pool of $30 Million. Any project that the Fund invests in must pass our thorough vetting process and meet or exceed our precise return expectations.
- Product Type: Multifamily (Value-Add or Ground Up New Construction)
- Target LP Returns: Minimum 2X Equity Multiple in each Deal cycle (2yr)
- Sub Markets with good economic fundamentals
- Rents and Return metrics meeting or exceeding our targets
- Controllable and forecastable expenses
- Easy access to Living Amenities
Learn more about the 10Y Model
Start Investing Alongside Us Today
The testimonials, statements, and opinions presented are applicable to the individuals listed. Results will vary and may not be representative of the experience of others. The testimonials are voluntarily provided and are not paid, nor were they provided with free products, services, or any benefits in exchange for said statements. The testimonials are representative of client experience, but the exact results and experience will be unique and individual to each client. All offers and sales of any securities will be made only to Accredited Investors, which for natural persons, are investors who meet certain minimum annual income or net worth thresholds or hold certain SEC approved certifications. Any securities that are offered, are offered in reliance on certain exemptions from the registration requirements of the Securities Act of 1933 (primarily Rule 506C of Regulation D and/or Section 4(a)(2) of the Act) and are not required to comply with specific disclosure requirements that apply to registrations under the Act. The SEC has not passed upon the merits of, or given its approval to any securities offered by Timberview Capital LLC, the terms of the offering, or the accuracy of completeness of any offering materials. Any securities that are offered by Timberview Capital LLC are subject to legal restrictions on transfer and resale and investors should not assume they will be able to resell any securities offered by Timberview Capital LLC. Investing in securities involves risk, and investors should be able to bear the loss of their investment. Any securities offered by Timberview Capital LLC are not subject to the protections of the Investment Company Act. Any performance data shared by Timberview Capital LLC represents past performance and past performance does not guarantee future results. Neither Timberview Capital LLC nor any of its funds are required by law to follow any standard methodology when calculating and representing performance data and the performance of any such funds may not be directly comparable to the performance of other private or registered funds.